Skip to main content

Table 5 Reclassification of patients with normal and clinically significant findings undergoing colonoscopy by means of faecal calprotectin measurement

From: Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness

Colonoscopy

Endoscopic findings probability model 2 including EPAGE criteria and faecal calprotectin values

Probability of findings

<30%

30-50%

>50%

Total

Endoscopic finding probability model 1 including EPAGE criteria

No findings

    

<30%

25

1

1

27

30-50%

100

13

10

123

>50%

0

0

0

0

Total

125

14

11

150

Significant findings

    

<30%

4

0

6

10

30-50%

11

10

43

64

>50%

0

0

0

0

 

Total

15

10

49

74

  1. Amongst patients with normal colonoscopy, 100 patients (66.7%) were correctly reclassified as at lower risk for endoscopic lesions and 12 patients (8.0%) were incorrectly reclassified as at higher risk. Amongst patients with significant findings at colonoscopy, 49 patients (66.2%) were correctly reclassified as at higher risk of endoscopic findings and 11 patients (14.9%) were incorrectly reclassified as at lower risk. The calculated NRI was 110.9% (P <0.001).